Report 1 : GENERAL PRINCIPLES AND THE RELEVANT CASES (<Session 6B>Safety assessment of biotechnology-derived pharmaceutical product.)

スポンサーリンク

概要

• 論文の詳細を見る
• 日本トキシコロジー学会の論文
• 1996-12-20

著者

• Maki Eiji

  Precli. Develop. Dept. Res. & Develop. Divi. Janssen-kyowa Co. Ltd.:japan Pharmaceutical Manufac

関連論文

• WI-01 The Present Status of ICH Guideline for Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
• Report 1 : GENERAL PRINCIPLES AND THE RELEVANT CASES (Safety assessment of biotechnology-derived pharmaceutical product.)
• INTRODUCTORY REMARKS (Safety assessment of biotechnology-derived pharmaceutical product.)

スポンサーリンク